Event Specialty: Bronchoscopy
Physicians, including pulmonologists and thoracic surgeons, will have the chance to see a demonstration of the MONARCH® Platform during the conference. Our team is excited to show attendees how MONARCH helps physicians reach difficult-to-access lung nodules with continuous vision, stability and precise micromovements.
Meet Dr Spira for a discussion about the Lung Cancer Initiative. Developing Transformative Innovation to Prevent, Intercept, and Treat Lung Cancer Monday, May 16, 2022 1:30-2:00pm PST
Please join us for a hosted reception. Waterbar 399 The Embarcadero San Francisco, CA 94105 Sunday, May 15 | 5:30-8:30pm PST
SESSION Not Your Grandfather’s CT Scan: Radiomic and Deep Machine Learning for Pulmonary Nodules and Lung Cancer Evaluation May 18 | 8:15am–9:45am Room 205–206, South Building, Level 2
PRESENTER Balaji Laxmanan, MD 8:55am–9:05am Automated Extraction and Longitudinal Analysis of Ground Glass Opacity Features in Lung Cancer Patients Powered by Natural Language Processing
PRESENTER Anil Vachani, MD 9:25am–9:35am Do Methods Matter in Diagnostic Yield Assessment in Bronchoscopy? A Simulation-Based Analysis
POSTER 316 May 15 | 2:15pm–3:45pmRoom 207–208, South Building, Level 2 Overall Survival Associated with Image-guided Thermal Ablation (IGTA) and Stereotactic Body Radiation Therapy (SBRT) for patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Regression Analysis
POSTER 1022 May 17 | 2:15pm–3:45pmRoom 3016–3018, West Building, Level 3 Big data approach to predicting lung cancer in a younger, real-world cohort Automated Extraction and Longitudinal Analysis of Ground Glass Opacity Features in Lung Cancer Patients Powered by Natural Language Processing
This innovative robotic platform is owned by Ethicon, Inc., part of the Johnson & Johnson MedTech Companies.
The American Thoracic Society (ATS) Conference 2022 is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition.Register for ATS 2022
Bronchoscopy Important Safety Statement:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology Important Safety Statement:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.